Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Dr R Shiffmann's Asthmador: relevant to our times, or a snake oil remedy?

Authors
Fedan-JS; Piedimonte-G
Source
Curr Opin Pharmacol 2010 Jun; 10(3):213-217
NIOSHTIC No.
20036975
Abstract
We really would have liked to have been able to title this issue: 'Cures for Respiratory Diseases Found!' But we and you reading this issue at the time of its publication realize that this claim cannot be made. Alas, lung researchers have amassed a gargantuan level of knowledge about the diseases that are discussed in this issue: how patients present; the several morphological and pathophysiological changes that occur as the disease begins and progresses; some genetic, possibly etiologic, predispositions; and the mechanisms of action of most of the drugs that are used to prevent and/or ameliorate patient symptoms. Not that the 'cure' for these diseases lies ultimately in pharmacotherapy. At the outset we decided to limit the areas covered by this issue to asthma and cystic fibrosis. This was not done to slight other diseases such as tuberculosis, pneumonia, sarcoidosis and the many others, but because of the limitations of space.
Keywords
Respiratory-system-disorders; Pulmonary-system-disorders; Lung-disease; Lung-disorders; Lung; Bronchial-asthma; Fibrosis; Fibrogenesis; Fibrogenicity
Contact
Jeffrey S Fedan, Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA
CODEN
COPUBK
Publication Date
20100601
Document Type
Other
Email Address
jsf2@cdc.gov
Fiscal Year
2010
NTIS Accession No.
NTIS Price
Issue of Publication
3
ISSN
1471-4892
NIOSH Division
HELD
Priority Area
Manufacturing
Source Name
Current Opinion in Pharmacology
State
WV
TOP